← Return to 2025 European Society for Medical Oncology (ESMO)

Discussion
smoore4 avatar

2025 European Society for Medical Oncology (ESMO)

Prostate Cancer | Last Active: Dec 17, 2025 | Replies (3)

Comment receiving replies
Profile picture for smoore4 @smoore4

Lutetium–PSMA-617 is Pluvicto.

Jump to this post


Replies to "Lutetium–PSMA-617 is Pluvicto."

@smoore4 You know, the more you think about it, it makes so much sense! Here is a drug that can SELECTIVELY kill PCa cells - not every cell in its path.
Dollars to donuts, in a few years they’ll be doing this more instead of present SRT regimens. Good find…
Phil